3.20.1 html 219 442 1 false 84 0 false 6 false false R1.htm 0001000 - Document - Cover page Sheet http://www.zosanopharma.com/role/CoverPage Cover page Cover 1 false false R2.htm 1001000 - Statement - BALANCE SHEETS Sheet http://www.zosanopharma.com/role/BalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.zosanopharma.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.zosanopharma.com/role/StatementsOfOperationsAndComprehensiveLoss STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 1003000 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY Sheet http://www.zosanopharma.com/role/StatementsOfChangesInStockholdersEquity STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY Statements 5 false false R6.htm 1004000 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.zosanopharma.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 2101100 - Disclosure - Organization Sheet http://www.zosanopharma.com/role/Organization Organization Notes 7 false false R8.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2103100 - Disclosure - Cash Equivalents and Investments in Marketable Securities Sheet http://www.zosanopharma.com/role/CashEquivalentsAndInvestmentsInMarketableSecurities Cash Equivalents and Investments in Marketable Securities Notes 9 false false R10.htm 2104100 - Disclosure - Balance Sheet Components Sheet http://www.zosanopharma.com/role/BalanceSheetComponents Balance Sheet Components Notes 10 false false R11.htm 2105100 - Disclosure - Leases Sheet http://www.zosanopharma.com/role/Leases Leases Notes 11 false false R12.htm 2106100 - Disclosure - Debt Financing Sheet http://www.zosanopharma.com/role/DebtFinancing Debt Financing Notes 12 false false R13.htm 2107100 - Disclosure - Stockholders' Equity Sheet http://www.zosanopharma.com/role/StockholdersEquity Stockholders' Equity Notes 13 false false R14.htm 2108100 - Disclosure - Warrants Sheet http://www.zosanopharma.com/role/Warrants Warrants Notes 14 false false R15.htm 2109100 - Disclosure - Stock-Based Compensation Sheet http://www.zosanopharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 15 false false R16.htm 2110100 - Disclosure - Commitments and Contingencies Sheet http://www.zosanopharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 2111100 - Disclosure - Income Taxes Sheet http://www.zosanopharma.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 2112100 - Disclosure - Employee Benefit Plan Sheet http://www.zosanopharma.com/role/EmployeeBenefitPlan Employee Benefit Plan Notes 18 false false R19.htm 2113100 - Disclosure - Subsequent Events Sheet http://www.zosanopharma.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 2303301 - Disclosure - Cash Equivalents and Investments in Marketable Securities (Tables) Sheet http://www.zosanopharma.com/role/CashEquivalentsAndInvestmentsInMarketableSecuritiesTables Cash Equivalents and Investments in Marketable Securities (Tables) Tables http://www.zosanopharma.com/role/CashEquivalentsAndInvestmentsInMarketableSecurities 22 false false R23.htm 2304301 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.zosanopharma.com/role/BalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.zosanopharma.com/role/BalanceSheetComponents 23 false false R24.htm 2305301 - Disclosure - Leases (Tables) Sheet http://www.zosanopharma.com/role/LeasesTables Leases (Tables) Tables http://www.zosanopharma.com/role/Leases 24 false false R25.htm 2306301 - Disclosure - Debt Financing (Tables) Sheet http://www.zosanopharma.com/role/DebtFinancingTables Debt Financing (Tables) Tables http://www.zosanopharma.com/role/DebtFinancing 25 false false R26.htm 2308301 - Disclosure - Warrants (Tables) Sheet http://www.zosanopharma.com/role/WarrantsTables Warrants (Tables) Tables http://www.zosanopharma.com/role/Warrants 26 false false R27.htm 2309301 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.zosanopharma.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.zosanopharma.com/role/StockBasedCompensation 27 false false R28.htm 2311301 - Disclosure - Income Taxes (Tables) Sheet http://www.zosanopharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.zosanopharma.com/role/IncomeTaxes 28 false false R29.htm 2402403 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 29 false false R30.htm 2402404 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfCashCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Details 30 false false R31.htm 2402405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Outstanding Common Stock Equivalents Excluded from Computations of Diluted Net Loss per Common Share (Details) Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfOutstandingCommonStockEquivalentsExcludedFromComputationsOfDilutedNetLossPerCommonShareDetails Summary of Significant Accounting Policies - Schedule of Outstanding Common Stock Equivalents Excluded from Computations of Diluted Net Loss per Common Share (Details) Details 31 false false R32.htm 2402406 - Disclosure - Summary of Significant Accounting Policies - New Lease Standards (Details) Sheet http://www.zosanopharma.com/role/SummaryOfSignificantAccountingPoliciesNewLeaseStandardsDetails Summary of Significant Accounting Policies - New Lease Standards (Details) Details 32 false false R33.htm 2403402 - Disclosure - Cash Equivalents and Investments in Marketable Securities - Summary of Cash Equivalents and Investments in Marketable Securities (Details) Sheet http://www.zosanopharma.com/role/CashEquivalentsAndInvestmentsInMarketableSecuritiesSummaryOfCashEquivalentsAndInvestmentsInMarketableSecuritiesDetails Cash Equivalents and Investments in Marketable Securities - Summary of Cash Equivalents and Investments in Marketable Securities (Details) Details 33 false false R34.htm 2403403 - Disclosure - Cash Equivalents and Investments in Marketable Securities - Unrealized Positions for Available-for-Sale Fixed-Maturity Debt Securities (Details) Sheet http://www.zosanopharma.com/role/CashEquivalentsAndInvestmentsInMarketableSecuritiesUnrealizedPositionsForAvailableForSaleFixedMaturityDebtSecuritiesDetails Cash Equivalents and Investments in Marketable Securities - Unrealized Positions for Available-for-Sale Fixed-Maturity Debt Securities (Details) Details 34 false false R35.htm 2404402 - Disclosure - Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.zosanopharma.com/role/BalanceSheetComponentsPrepaidExpensesAndOtherCurrentAssetsDetails Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) Details 35 false false R36.htm 2404403 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Detail) Sheet http://www.zosanopharma.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentDetail Balance Sheet Components - Schedule of Property and Equipment (Detail) Details 36 false false R37.htm 2404404 - Disclosure - Balance Sheet Components - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/BalanceSheetComponentsAdditionalInformationDetail Balance Sheet Components - Additional Information (Detail) Details 37 false false R38.htm 2404405 - Disclosure - Balance Sheet Components - Other Accrued Liabilities (Details) Sheet http://www.zosanopharma.com/role/BalanceSheetComponentsOtherAccruedLiabilitiesDetails Balance Sheet Components - Other Accrued Liabilities (Details) Details 38 false false R39.htm 2405402 - Disclosure - Leases - Narrative (Details) Sheet http://www.zosanopharma.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 39 false false R40.htm 2405404 - Disclosure - Leases - Description of Lease Costs (Details) Sheet http://www.zosanopharma.com/role/LeasesDescriptionOfLeaseCostsDetails Leases - Description of Lease Costs (Details) Details 40 false false R41.htm 2405405 - Disclosure - Leases - Description of Cash Payment (Details) Sheet http://www.zosanopharma.com/role/LeasesDescriptionOfCashPaymentDetails Leases - Description of Cash Payment (Details) Details 41 false false R42.htm 2405406 - Disclosure - Leases - Description of Other Lease Information (Details) Sheet http://www.zosanopharma.com/role/LeasesDescriptionOfOtherLeaseInformationDetails Leases - Description of Other Lease Information (Details) Details 42 false false R43.htm 2405407 - Disclosure - Leases - Future Minimum Lease Payments (Details) Sheet http://www.zosanopharma.com/role/LeasesFutureMinimumLeasePaymentsDetails Leases - Future Minimum Lease Payments (Details) Details 43 false false R44.htm 2406402 - Disclosure - Debt Financing - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/DebtFinancingAdditionalInformationDetail Debt Financing - Additional Information (Detail) Details 44 false false R45.htm 2406403 - Disclosure - Debt Financing - Summary of Debt Obligations (Details) Sheet http://www.zosanopharma.com/role/DebtFinancingSummaryOfDebtObligationsDetails Debt Financing - Summary of Debt Obligations (Details) Details 45 false false R46.htm 2406404 - Disclosure - Debt Financing - Summary of Long-Term Debt, Net of Unamortized Debt Discount and Issuance Costs (Detail) Sheet http://www.zosanopharma.com/role/DebtFinancingSummaryOfLongTermDebtNetOfUnamortizedDebtDiscountAndIssuanceCostsDetail Debt Financing - Summary of Long-Term Debt, Net of Unamortized Debt Discount and Issuance Costs (Detail) Details 46 false false R47.htm 2406405 - Disclosure - Debt Financing - Future Minimum Payments on the Company's Current Debt, Including Payment of Principal and Interest (Detail) Sheet http://www.zosanopharma.com/role/DebtFinancingFutureMinimumPaymentsOnCompanysCurrentDebtIncludingPaymentOfPrincipalAndInterestDetail Debt Financing - Future Minimum Payments on the Company's Current Debt, Including Payment of Principal and Interest (Detail) Details 47 false false R48.htm 2407401 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/StockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 48 false false R49.htm 2408402 - Disclosure - Warrants - Summary of Warrants Issued and Outstanding (Details) Sheet http://www.zosanopharma.com/role/WarrantsSummaryOfWarrantsIssuedAndOutstandingDetails Warrants - Summary of Warrants Issued and Outstanding (Details) Details 49 false false R50.htm 2408403 - Disclosure - Warrants - Additional Information (Details) Sheet http://www.zosanopharma.com/role/WarrantsAdditionalInformationDetails Warrants - Additional Information (Details) Details 50 false false R51.htm 2409402 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/StockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 51 false false R52.htm 2409403 - Disclosure - Stock-Based Compensation - Summary of Stock Option and Award Activity Excluding Inducement Grants (Detail) Sheet http://www.zosanopharma.com/role/StockBasedCompensationSummaryOfStockOptionAndAwardActivityExcludingInducementGrantsDetail Stock-Based Compensation - Summary of Stock Option and Award Activity Excluding Inducement Grants (Detail) Details 52 false false R53.htm 2409404 - Disclosure - Stock-Based Compensation - Summary of Company's Inducement Grant Stock Option Activities (Detail) Sheet http://www.zosanopharma.com/role/StockBasedCompensationSummaryOfCompanysInducementGrantStockOptionActivitiesDetail Stock-Based Compensation - Summary of Company's Inducement Grant Stock Option Activities (Detail) Details 53 false false R54.htm 2409405 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) Sheet http://www.zosanopharma.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) Details 54 false false R55.htm 2409406 - Disclosure - Stock-Based Compensation - Schedule of Weighted-Average Assumptions for the Black-Scholes Option-Pricing Model Used in Determining the Fair Value of Options Granted to Employees (Detail) Sheet http://www.zosanopharma.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsForBlackScholesOptionPricingModelUsedInDeterminingFairValueOfOptionsGrantedToEmployeesDetail Stock-Based Compensation - Schedule of Weighted-Average Assumptions for the Black-Scholes Option-Pricing Model Used in Determining the Fair Value of Options Granted to Employees (Detail) Details 55 false false R56.htm 2410401 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 56 false false R57.htm 2411402 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 57 false false R58.htm 2411403 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail) Sheet http://www.zosanopharma.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToCompanysEffectiveTaxRateDetail Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail) Details 58 false false R59.htm 2411404 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail) Sheet http://www.zosanopharma.com/role/IncomeTaxesComponentsOfNetDeferredTaxAssetsAndLiabilitiesDetail Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Detail) Details 59 false false R60.htm 2411405 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Detail) Sheet http://www.zosanopharma.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetail Income Taxes - Schedule of Unrecognized Tax Benefits (Detail) Details 60 false false R61.htm 2412401 - Disclosure - Employee Benefit Plan - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/EmployeeBenefitPlanAdditionalInformationDetail Employee Benefit Plan - Additional Information (Detail) Details 61 false false R62.htm 2413401 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.zosanopharma.com/role/SubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 62 false false All Reports Book All Reports zsan-20191231.xml zsan-20191231.xsd zsan-20191231_cal.xml zsan-20191231_def.xml zsan-20191231_lab.xml zsan-20191231_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2019-01-31 true true